Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation Aerosol
In a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA)."
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: AccuNeb | Albuterol | Biotechnology | Food and Drug Administration (FDA) | New Drug Applications | Pharmaceuticals | Proair HFA | USA Health | Ventolin